This inventor holds 2 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: National Institute of Health and Medical Research, Assistance Publique-Hopitaux De Paris. Active years: 2014-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 1,853 
1 out of 331 
Years Active: 2014-2018
Title: Olivier Blanc-Brude: Innovator in Hemolytic Disease Treatments
Introduction
Olivier Blanc-Brude is a notable inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the treatment of hemolytic diseases. With a total of 2 patents, his work focuses on innovative methods that aim to improve patient outcomes.
Latest Patents
Blanc-Brude's latest patents include groundbreaking methods for treating vaso-occlusive crises associated with sickle cell disease. One of his inventions relates to determining the risk of severe complications in hemolytic diseases. This method involves assessing the level of cell microparticles in a blood sample from the patient and measuring the heme and/or hemoglobin contained in those microparticles. Additionally, he has developed a method for preventing vaso-occlusive crises by depleting blood-borne microparticles laden with heme and hemoglobin. Another significant patent involves an in vitro method for preparing progenitor cells with increased adhesivity, achieved by contacting these cells with an agonist of the CD47/IAP receptor.
Career Highlights
Throughout his career, Olivier Blanc-Brude has worked with esteemed organizations such as the National Institute of Health and Medical Research and Assistance Publique-Hôpitaux de Paris. His experience in these institutions has allowed him to advance his research and contribute to the medical community.
Collaborations
Blanc-Brude has collaborated with notable colleagues, including Sylvain Lejeune and François Lionnet. These partnerships have further enriched his research endeavors and have led to innovative solutions in the field of hemolytic diseases.
Conclusion
Olivier Blanc-Brude's contributions to medical research, particularly in the treatment of hemolytic diseases, highlight his innovative spirit and dedication to improving patient care. His patents reflect a commitment to advancing medical science and providing new hope for patients suffering from these conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile